Literature DB >> 8450053

Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts.

S V Pande1, M Brivet, A Slama, F Demaugre, C Aufrant, J M Saudubray.   

Abstract

Deficiency of the enzymes of mitochondrial fatty acid oxidation and related carnitine dependent steps have been shown to be one of the causes of the fasting-induced hypoketotic hypoglycemia. We describe here carnitine-acylcarnitine translocase deficiency in a neonate who died eight days after birth. The proband showed severe fasting-induced hypoketotic hypoglycemia, high plasma creatine kinase, heartbeat disorder, hypothermia, and hyperammonemia. The plasma-free carnitine on day three was only 3 microM, and 92% of the total carnitine (37 microM) was present as acylcarnitine. Treatments with intravenous glucose, carnitine, and medium-chain triglycerides had been tried without improvements. Measurements in fibroblasts confirmed deficient oxidation of palmitate and showed normal activities of the carnitine palmitoyltransferases I and II and of the three acyl-CoA dehydrogenases. A total deficiency of the carnitine-acyl-carnitine translocase was found in fibroblasts using the carnitine acetylation assay (1986. Biochem. J. 236:143-148). This assay has been further simplified by seeking conditions permitting application to permeabilized fibroblasts and lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450053      PMCID: PMC288085          DOI: 10.1172/JCI116288

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Fuel homeostasis in exercise.

Authors:  P Felig; J Wahren
Journal:  N Engl J Med       Date:  1975-11-20       Impact factor: 91.245

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Regulation of hepatic fatty acid oxidation and ketone body production.

Authors:  J D McGarry; D W Foster
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

4.  Decreased ketogenesis due to deficiency of hepatic carnitine acyl transferase.

Authors:  P F Bougneres; J M Saudubray; C Marsac; O Bernard; M Odievre; J R Girard
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

5.  Deficiency of electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts.

Authors:  F E Frerman; S I Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Inhibition of mitochondrial carnitine-acylcarnitine translocase by sulfobetaines.

Authors:  R Parvin; T Goswami; S V Pande
Journal:  Can J Biochem       Date:  1980-10

7.  Muscle carnitine palmityltransferase deficiency and myoglobinuria.

Authors:  S DiMauro; P M DiMauro
Journal:  Science       Date:  1973-11-20       Impact factor: 47.728

8.  Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.

Authors:  J M Saudubray; F X Coudé; F Demaugre; C Johnson; K M Gibson; W L Nyhan
Journal:  Pediatr Res       Date:  1982-10       Impact factor: 3.756

9.  Carnitine-acylcarnitine translocase catalyzes an equilibrating unidirectional transport as well.

Authors:  S V Pande; R Parvin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

10.  Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome.

Authors:  P R Chapoy; C Angelini; W J Brown; J E Stiff; A L Shug; S D Cederbaum
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

View more
  16 in total

1.  Carnitine-acylcarnitine translocase deficiency is a treatable disease.

Authors:  A I al Aqeel; M S Rashed; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Impaired peroxisomal fatty acid oxidation in human skin fibroblasts with a mitochondrial acylcarnitine/carnitine translocase deficiency.

Authors:  B S Jakobs; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

3.  Retrospective diagnosis of carnitine-acylcarnitine translocase deficiency by acylcarnitine analysis in the proband Guthrie card and enzymatic studies in the parents.

Authors:  M Brivet; A Slama; D S Millington; C R Roe; F Demaugre; A Legrand; A Boutron; F Poggi; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 4.  L-Carnitine.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

5.  A patient with lethal cardiomyopathy and a carnitine-acylcarnitine translocase deficiency.

Authors:  K E Niezen-Koning; F J van Spronsen; L Ijlst; R J Wanders; M Brivet; M Duran; D J Reijngoud; H S Heymans; G P Smit
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis.

Authors:  M Brivet; A Slama; H Ogier; A Boutron; F Demaugre; J M Saudubray; A Lemonnier
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 7.  Defects in activation and transport of fatty acids.

Authors:  M Brivet; A Boutron; A Slama; C Costa; L Thuillier; F Demaugre; D Rabier; J M Saudubray; J P Bonnefont
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

8.  Medium-chain triglyceride loading test in carnitine-acylcarnitine translocase deficiency: insights on treatment.

Authors:  R Parini; F Invernizzi; F Menni; B Garavaglia; D Melotti; M Rimoldi; S Salera; C Tosetto; F Taroni
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

Review 9.  Mammalian mitochondrial beta-oxidation.

Authors:  S Eaton; K Bartlett; M Pourfarzam
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

10.  The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.

Authors:  Ronald J A Wanders; Jos P N Ruiter; Lodewijk IJLst; Hans R Waterham; Sander M Houten
Journal:  J Inherit Metab Dis       Date:  2010-05-20       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.